Concepedia

Lipoprotein-Associated Phospholipase A2 Bound on High-Density Lipoprotein Is Associated With Lower Risk for Cardiac Death in Stable Coronary Artery Disease Patients

Lοukianos S. Rallidis, Constantinos C. Tellis, John Lekakis, Ioannis Rizos, Christos Varounis, Athanasios Charalampopoulos, Maria Zolindaki, Nikolaos Dagres, Maria Anastasiou‐Nana, Alexandros D. Tselepis

Journal of the American College of Cardiology · 2012 · 59 citations · 33 references

DOI

Concepts

References

33

International Physical Activity Questionnaire: 12-Country Reliability and Validity

Cora L. Craig, Alison L. Marshall, Adrian Bauman et al. · Medicine & Science in Sports & Exercise · 2003 · 21.6K citations

, , +14

Dietary patterns: A Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk

Demosthenes B. Panagiotakos, Christos Pitsavos, Christodoulos Stefanadis · Nutrition Metabolism and Cardiovascular Diseases · 2006 · 982 citations

, , +17

Effects of the Direct Lipoprotein-Associated Phospholipase A <sub>2</sub> Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque

Patrick W. Serruys, Héctor M. García‐García, Paweł Buszman et al. · Circulation · 2008 · 505 citations · Full text

, , +17

Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.

Diana M. Stafforini, Thomas M. McIntyre, M.E. Carter et al. · Journal of Biological Chemistry · 1987 · 402 citations · Full text

, , +15

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

Colin H. Macphee, Kitty Moores, Helen Boyd et al. · Biochemical Journal · 1999 · 337 citations · Full text

, , +17